AgingResearch.News
Frontiers in Cardiovascular Medicine

Early evolocumab improves lipid profile, inflammation and short-term outcomes in non-revascularized CHIP-NSTEACS patients: a retrospective cohort study

By Wenlong Jiang, Mei Liu, Xiaoshuan Xiong, Jing Cheng, Fangzhou Cheng
Figure 1. Forest plot of multivariate Cox proportional hazards regression analysis identifying independent predictors of 3-month major adverse cardiovascular events (MACE) in non-revascularized CHIP-NSTEACS…
Open the figure at full size
Figure 1. Forest plot of multivariate Cox proportional hazards regression analysis identifying independent predictors of 3-month major adverse cardiovascular events…Forest plot of multivariate Cox proportional hazards regression analysis identifying independent predictors of 3-month major adverse cardiovascular events (MACE) in non-revascularized CHIP-NSTEACS patients after inverse probability of treatment weighting adjustment.Jiang et al.
Cohort study of 186 peopleInterventions

3 months, declared no competing interests

Paper

The paper

Wenlong Jiang, Mei Liu, Xiaoshuan Xiong, Jing Cheng, Fangzhou Cheng

Shenzhen Yantian District People’s Hospital

Frontiers in Cardiovascular Medicine, 12 Aug 2026

doi.org/10.3389/fcvm.2026.1901995PubMed 42656687

More on Inflammation